Is this you? Create Your Porfile
Avatar

Olaf Prien

Bayer HealthCare Pharmaceuticals

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Olaf Prien is active.

Explore More

Publication

Featured researches published by Olaf Prien.

Archive | 2002

Cdk inhibiting pyrimidines, production thereof and their use as medicaments

Thomas Brumby; Rolf Jautelat; Olaf Prien; Martina Schäfer; Gerhard Siemeister; Ulrich Lücking; Christoph Huwe

Archive | 2006

Substituted imidazo[1,2b]pyridazines as kinase inhibitors, the production thereof, and use of the same as medicaments

Olaf Prien; Benjamin Bader; Ulrich Zügel; Stuart Ince; Christoph Huwe; Karina Schuck; Knut Eis; Ulrich Lücking; Rolf Jautelat; Judith Günther; Manfred Husemann

Archive | 2006

Sulfoximine-substituted pyrimidines , their preparation and use as drugs

Ulrich Luecking; Duy Nguyen; Bonin Arne Von; Ahsen Oliver Von; Martin Krueger; Hans Briem; Georg Kettschau; Olaf Prien; Anne Mengel; Konrad Krolikiewicz; Ulf Boemer; Ulrich Bothe; Ingo Hartung

Archive | 2007

PYRAZOLOPYRIMIDINES AND SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, METHODS OF PREPARING SAME AND USES OF SAME.

Stuart Ince; Olaf Prien; Shoufu Lu; Hongyi Yu; Manfred Husemann; Karina Schuck

Archive | 2008

Novel sulphoximine-substituted quinazoline and quinazoline derivatives as kinase inhibitors

Knut Eis; Olaf Prien; Ulrich Luecking; Judith Guenther; Dieter Zopf; Dirk Brohm; Verena Vöhringer; Elisabeth Woltering; Hartmut Beck; Mario Lobell; Volkhart Min-Jian Li; Susanne Greschat

Archive | 2007

OXO-SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINES, PRODUCTION AND USE THEREOF AS DRUGS

Olaf Prien; Knut Eis; Benjamin Bader; Judith Guenther; Von Arne Bonin

Archive | 2005

Meta-substituted thiazolidinones, the production thereof and their use as medicaments

Volker Schulze; Knut Eis; Lars Wortmann; Dirk Kosemund; Olaf Prien; Gerhard Siemeister; Holger Hess-Stumpp; Uwe Eberspächer; Imadul Islam

Archive | 2006

Thiazolidinones for use as inhibitors of polo-like kinase (plk)

Volker Schulze; Knut Eis; Lars Wortmann; Dirk Kosemund; Olaf Prien; Gerhard Siemeister; Holger Hess-Stumpp; Uwe Eberspaecher; Damian O. Arnaiz

Archive | 2007

QUINAZOLINE DERIVATIVES, THEIR PREPARATION, THEIR USE, AND MEDICAMENTS COMPRISING THEM

Olaf Prien; Knut Eis; Wolfgang Schwede; Judith Guenther; Dieter Zopf; Dominic E. A. Brittain

Archive | 2006

New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents

Olaf Prien; Volker Schulze; Knut Eis; Lars Wortmann; Dirk Kosemund; Gerhard Siemeister; Uwe Eberspaecher; Judith Guenther; Dominic E. A. Brittain

Explore More

Collaboration

Dive into the Olaf Prien's collaboration.

Top Co-Authors
Avatar

Knut Eis

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Judith Guenther

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Dieter Zopf

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Gerhard Siemeister

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Dirk Kosemund

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Dominic E. A. Brittain

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Lars Wortmann

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Ulrich Lücking

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Volker Schulze

Bayer HealthCare Pharmaceuticals

View shared research outputs
Top Co-Authors
Avatar

Alexander Hillisch

Bayer Corporation

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge